Search

Type

Audience

Category

Issue

Last updated

Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.

Displaying 1 - 3 of 3 items.

Health alert or recall Importation of US Clinical Trial-Labelled Remdesivir for Injection Due to Shortage of Canadian-Labelled Remdesivir
… On July 27, 2020, Health Canada authorized VEKLURY® (remdesivir) with conditions to treat COVID-19 in adults and … of this product in Canada, Health Canada has added Remdesivir from the US intended for clinical trials with … for Canadian patients ahead of the Canadian-labelled VEKLURY being marketed. Healthcare professionals are advised …
AlertHealth professional risk communication | 2020-09-15
Health alert or recall Remdesivir authorized with conditions for the treatment of patients in Canada with severe COVID-19 symptoms
… – Health Canada has authorized with conditions the drug remdesivir (brand name Veklury) manufactured by Gilead Sciences Canada, Inc. for the … pneumonia and require extra oxygen to help them breathe. Remdesivir is the first drug that Health Canada has …
AlertPublic advisory | 2020-07-28
Health alert or recall Chloroquine and hydroxychloroquine can have serious side effects. These drugs should be used only under the supervision of a physician.
… granted authorization with conditions  for the use of Veklury (remdesivir) to treat COVID-19 in patients with pneumonia requiring supplemental oxygen. Remdesivir is the first drug to be authorized in Canada for …
AlertInformation update | 2020-04-25
Report a problem or mistake on this page
What was wrong?

You will not receive a reply. Telephone numbers and e-mail addresses will be removed.

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.